The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein.

Clinical and Experimental Immunology
Martin OppermannPeter F Zipfel

Abstract

The complement inhibitor Factor H has three distinct binding sites for C3b and for heparin, but in solution uses specifically the most C-terminal domain, i.e. short consensus repeats (SCR) 20 for ligand interaction. Two novel monoclonal antibodies (mABs C14 and C18) that bind to the most C-terminal domain SCR 20 completely blocked interaction of Factor H with the ligands C3b, C3d, heparin and binding to endothelial cells. In contrast, several mAbs that bind to the N-terminus and to the middle regions of the molecule showed no or minor inhibitory effects when assayed by enzyme-linked immunosorbent assay (ELISA) and ligand interaction assays. This paradox between a single functional binding site identified for native Factor H versus multiple interaction sites reported for deletion constructs is explained by a compact conformation of the fluid phase protein with one accessible binding site. On zymosan particles mAbs C14 and C18 blocked alternative pathway activation completely. Thus demonstrating that native Factor H makes the first and initial contact with the C terminus, which is followed by N terminally mediated complement regulation. These results are explained by a conformational hypothetical model: the native Factor H protei...Continue Reading

References

Oct 1, 1996·Proceedings of the National Academy of Sciences of the United States of America·A K Sharma, M K Pangburn
Jul 17, 1999·Immunopharmacology·P F ZipfelS Meri
Jun 6, 2000·The Journal of Biological Chemistry·T S JokirantaS Meri
Feb 7, 2001·Journal of the American Society of Nephrology : JASN·Jessica CaprioliMarina Noris
Feb 15, 2001·American Journal of Human Genetics·D Pérez-CaballeroP Sánchez-Corral
Apr 12, 2001·The New England Journal of Medicine·M J Walport
Feb 28, 2002·Annual Review of Immunology·Charles A Janeway, Ruslan Medzhitov
Oct 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michael K Pangburn
Nov 9, 2002·American Journal of Human Genetics·Pilar Sánchez-CorralSantiago Rodríguez de Córdoba
Dec 10, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jens HellwageSeppo Meri
Jul 20, 2005·Molecular Immunology·Peter F ZipfelChristine Skerka
Sep 30, 2005·The American Journal of Pathology·T Sakari JokirantaPeter F Zipfel

❮ Previous
Next ❯

Citations

Feb 15, 2011·Nature Structural & Molecular Biology·Hugh P MorganJonathan P Hannan
Feb 13, 2008·Proceedings of the National Academy of Sciences of the United States of America·Federica CastellettiMarina Noris
Oct 24, 2009·The Journal of Biological Chemistry·Azubuike I OkemefunaStephen J Perkins
Dec 3, 2009·The Journal of Biological Chemistry·Jonatan LefflerMyriam Martin
May 28, 2010·The Journal of Biological Chemistry·Vaibhav AgarwalSven Hammerschmidt
Jul 17, 2008·Genetic Testing·Christian GöttingKnut Kleesiek
Feb 1, 2012·The Journal of Infectious Diseases·Mónica Marcela Castiblanco-ValenciaAngela Silva Barbosa
Aug 12, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Stefanie StrobelMihály Józsi
Nov 28, 2007·Infection and Immunity·Judith BehnsenPeter F Zipfel
Nov 23, 2010·Current Rheumatology Reports·Bill GiannakopoulosSteven A Krilis
Feb 17, 2010·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Peter F ZipfelUNKNOWN European DEAP-HUS Study Group
Feb 16, 2013·Experimental Eye Research·Paul J Park, Deepak Shukla
Feb 19, 2013·Archivos de la Sociedad Española de Oftalmología·F Cruz-GonzálezR González-Sarmiento
Jun 10, 2009·Journal of Molecular Biology·Azubuike I OkemefunaStephen J Perkins
Jun 10, 2009·Journal of Molecular Biology·Azubuike I OkemefunaStephen J Perkins
May 30, 2007·Seminars in Nephrology·Tipu S Puri, Richard J Quigg
Feb 6, 2008·International Journal of Medical Microbiology : IJMM·Catherine A BrissetteBrian Stevenson
Dec 18, 2007·Clinical and Experimental Immunology·C Q SchmidtP N Barlow
May 4, 2011·Journal of Thrombosis and Haemostasis : JTH·P G de Groot, J C M Meijers
May 24, 2014·Clinical and Experimental Immunology·A M BlomM Okroj
Jul 8, 2008·Trends in Immunology·Mihály Józsi, Peter F Zipfel
Aug 22, 2006·Molecular Immunology·Jessy J Alexander, Richard J Quigg
Aug 3, 2013·Protein Expression and Purification·Feng-Mei WangMing-Hui Zhao
Jan 11, 2011·Journal of Immunological Methods·Lubka T RoumeninaVeronique Fremeaux-Bacchi
Jun 18, 2015·Frontiers in Immunology·Nicolas S MerleLubka T Roumenina

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.